1/9
11:08 am
hcat
Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Citigroup Inc. from $3.25 to $2.75. They now have a "neutral" rating on the stock.
Low
Report
Health Catalyst (NASDAQ:HCAT) had its price target lowered by analysts at Citigroup Inc. from $3.25 to $2.75. They now have a "neutral" rating on the stock.
12/2
06:59 am
hcat
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
Medium
Report
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
11/14
04:14 pm
hcat
Health Catalyst to Participate in Upcoming Investor Conferences
Low
Report
Health Catalyst to Participate in Upcoming Investor Conferences